The use of chelating agents in the treatment of acute and chronic lead intoxication in childhood.
about
Description of 3,180 courses of chelation with dimercaptosuccinic acid in children ≤ 5 y with severe lead poisoning in Zamfara, Northern Nigeria: a retrospective analysis of programme dataUnanswered questions in metal chelationOccupational and community exposures to toxic metals: lead, cadmium, mercury and arsenicGasoline sniffing and lead encephalopathyPerspective on lead toxicity, a comparison between the United States and IranRecognition and management of children with increased lead absorptionChelation for Heavy Metals (Arsenic, Lead, and Mercury): Protective or Perilous?Lead(II) binding to the chelating agent D-penicillamine in aqueous solutionAdverse effects of reduced-dose d-penicillamine in children with mild-to-moderate lead poisoning.Lead and zinc concentrations in plasma, erythrocytes, and urine in relation to ALA-D activity after intravenous infusion of Ca-EDTA.Safety and efficacy of meso-2,3-dimercaptosuccinic acid (DMSA) in children with elevated blood lead concentrations.Experimental lead intoxication in dogs: a comparison of blood lead and urinary delta-aminolevulinic acid following intoxication and chelation therapy.Effects of an EDTA infusion on the urinary elimination of several elements in healthy subjects.Variations in hematologic responses to increased lead absorption in young children.Evaluation of the potential role of chelation therapy in treatment of low to moderate lead exposures.Effects of chelating agents on oral uptake and renal deposition and excretion of cadmium.Indices of potential lead hazard.Deaths from acute lead poisoning.Succimer chelation improves learning, attention, and arousal regulation in lead-exposed rats but produces lasting cognitive impairment in the absence of lead exposure.Screening for lead poisoning with the urinary ALA test.Management of Lead Encephalopathy with DMSA After Exposure to Lead-Contaminated MoonshineLead encephalopathy from an imported Toby mug.Lead poisoning treated with haemodialysis.Neurological syndromes produced by some toxic metals encountered industrially or environmentally.The characteristics of an adverse effect: using the example of developing a standard for lead.Lead encephalopathy. A case report and review of management.Chelation therapy for childhood lead poisoning. The changing scene in the 1990s.The current status of lead poisoning in children.Bullet fragment-induced lead arthropathy with subsequent fracture and elevated blood lead levels.Protective Effects of Lactobacillus plantarum CCFM8246 against Copper Toxicity in Mice.Chelation therapy.Computer simulation of chelation therapy. Plasma mobilizing index as a replacement for effective stability constant.Are children still at risk for lead poisoning?Metal chelators and neurotoxicity: lead, mercury, and arsenic.Lead concentration in human brain tissue: an autopsy study.Clinical services in environmental pediatrics.Lead health effects in drinking water.Oral D-penicillamine and intramuscular BAL+EDTA in the treatment of lead accumulation.Management of childhood lead poisoning: clinical impact and cost-effectiveness.Laboratory diagnosis of increased lead absorption.
P2860
Q21562279-56CC6217-5E79-42BB-8EB5-A5C10A0C527AQ23918293-45C57513-ABEE-4A10-AC1B-08EA3701520BQ23922879-B7259C9E-BF6F-4EA9-A730-B5645D50B3A4Q24682649-CDFFD7FB-FCD9-486F-BAA8-727FA783F44DQ28393598-DFC37981-2C61-475F-9AA2-047B4C628B72Q28768101-77AB1C70-09D3-4789-AC2B-595F7E235C80Q29392957-EEE9F82A-BE13-4B14-8230-6F1705DEB5A3Q30868634-D9121780-F90F-4B9B-B7C8-EAB73A916C61Q33331436-AFF9AFC4-9480-40AD-AB25-510BBCEC3E71Q33576262-1D7B4371-A1D4-446B-AEAA-BF03A04EB040Q33912579-A62E872E-4AFC-4735-B7E7-F9E97BC4D957Q34119522-D5EB1ED3-51FB-4D72-B48A-B3C3E968F691Q34358052-7A4776CA-427B-455C-84E7-478E743269A2Q34663423-AC5C3685-93A7-4152-B2E0-BF0464E147FDQ35033468-841E85A3-5DAD-4EEA-A595-6821B2C511D0Q35034556-2B1C41A7-AD24-48C4-BD34-DBED4C394906Q35133194-BA9CB9C5-CB90-4531-AC33-042C7BA2D964Q35149825-19687E4B-273A-49B2-B3AF-AD72D1131D43Q35695403-D9A1ED90-6F6D-4639-A032-ABBA44681BF6Q35920911-4DA65981-0949-4C00-A3FE-9AE5E0B10993Q36362756-C3717EA6-2FCB-4C3D-BDF3-AFAC5AF1D0B0Q36723136-BF1B414C-36FF-4A56-A871-960B8D36D4AAQ39620655-49CA0A6A-D7B4-46EE-B2DA-3A665A46CC21Q39769893-5CE89B00-7228-4A81-B28E-50881413CE40Q39843241-358D8537-5EC2-4DF3-A6E5-C3678E4BCBE1Q39858847-409A3B22-0990-4795-BE04-120B24BB711EQ40855805-CA3A1BF5-17F4-4CB7-876A-43BA55D36125Q41212005-A463A287-29C4-4F3F-AF5B-BA21B7C3A76DQ42329999-560A618D-9CCF-40BB-B9AB-B1789C073E64Q42763431-32E6CAFF-3BB5-4089-BE20-C70400B3ABB2Q42790777-E7C39E69-FF0B-4EFD-A01E-F49A3D071BD3Q45055410-E2DBB7B3-0CC3-4936-B8CB-F3B04380931DQ47813555-F47E6F46-ECB4-4472-A9F2-EFC3DA071B5BQ48141711-2EBCEFE4-595F-47A1-BBFD-0820B856F403Q48615812-256C3082-993C-4697-ABFD-3C1BD8113851Q50313113-E72AA52F-8207-4285-97E1-A2FFD0B6DB1EQ52619824-D90C89C0-97BB-46C7-9051-A5F23A075FDFQ52737250-56B65C7F-1BC9-4A7D-83F1-4DF4E936F8F5Q53651728-48A88DA1-C196-48F4-B395-11D1E4069A75Q54019215-D0189DEA-79FD-467E-86CB-74FEACF7DCCB
P2860
The use of chelating agents in the treatment of acute and chronic lead intoxication in childhood.
description
1968 nî lūn-bûn
@nan
1968年の論文
@ja
1968年論文
@yue
1968年論文
@zh-hant
1968年論文
@zh-hk
1968年論文
@zh-mo
1968年論文
@zh-tw
1968年论文
@wuu
1968年论文
@zh
1968年论文
@zh-cn
name
The use of chelating agents in ...... ead intoxication in childhood.
@en
type
label
The use of chelating agents in ...... ead intoxication in childhood.
@en
prefLabel
The use of chelating agents in ...... ead intoxication in childhood.
@en
P1476
The use of chelating agents in ...... ead intoxication in childhood.
@en
P2093
Chisolm JJ Jr
P356
10.1016/S0022-3476(68)80036-8
P407
P577
1968-07-01T00:00:00Z